WallStSmart

Auna S.A. (AUNA)vsDaVita HealthCare Partners Inc (DVA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 211% more annual revenue ($13.64B vs $4.39B). DVA leads profitability with a 5.5% profit margin vs 2.2%. AUNA trades at a lower P/E of 14.8x. DVA earns a higher WallStSmart Score of 66/100 (B-).

AUNA

Hold

49

out of 100

Grade: D+

Growth: 5.3Profit: 5.0Value: 5.7Quality: 3.0
Piotroski: 4/9Altman Z: 0.92

DVA

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 8.7Quality: 4.3
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AUNASignificantly Overvalued (-88.4%)

Margin of Safety

-88.4%

Fair Value

$2.58

Current Price

$5.82

$3.24 premium

UndervaluedFair: $2.58Overvalued
DVAUndervalued (+11.7%)

Margin of Safety

+11.7%

Fair Value

$163.40

Current Price

$155.11

$8.29 discount

UndervaluedFair: $163.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AUNA2 strengths · Avg: 9.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

DVA3 strengths · Avg: 8.7/10
Return on EquityProfitability
64.8%10/10

Every $100 of equity generates 65 in profit

PEG RatioValuation
0.568/10

Growing faster than its price suggests

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

Areas to Watch

AUNA4 concerns · Avg: 2.8/10
Market CapQuality
$417.43M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
2.2%3/10

2.2% margin — thin

EPS GrowthGrowth
-50.9%2/10

Earnings declined 50.9%

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AUNA

The strongest argument for AUNA centers on Price/Book, P/E Ratio.

Bull Case : DVA

The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.

Bear Case : AUNA

The primary concerns for AUNA are Market Cap, Return on Equity, Profit Margin. Debt-to-equity of 2.23 is elevated, increasing financial risk. Thin 2.2% margins leave little buffer for downturns.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

DVA is growing revenue faster at 9.9% — sustainability is the question.

DVA generates stronger free cash flow (395M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DVA scores higher overall (66/100 vs 49/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Auna S.A.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Auna S.A. is a leading telecommunications and digital services provider in Latin America, delivering integrated solutions that enhance connectivity and customer experience. The company offers a wide range of services, including high-speed internet, television, and mobile offerings, serving both residential and business clients across diverse markets. Auna's commitment to innovation and exceptional customer care has solidified its position as a significant player in the region's evolving digital landscape, while its robust infrastructure positions it well to capitalize on the increasing demand for advanced telecom solutions, presenting valuable growth opportunities for institutional investors.

Visit Website →

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Want to dig deeper into these stocks?